The idiopathic hypereosinophilic syndrome and eosinophilic leukemias.
Bain
Barbara
B
Department of Hematology, St. Mary's Hospital Campus, Imperial College Faculty of Medicine, Praed Street, London, W2 1NY, UK. b.bain@imperial.ac.uk
D001549:Benzamides; D002999:Clone Cells / Q000378:metabolism / Q000473:pathology; D016207:Cytokines / Q000502:physiology; D004802:Eosinophilia / Q000209:etiology; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D000068877:Imatinib Mesylate; D008223:Lymphoma / Q000150:complications / Q000503:physiopathology; D008954:Models, Biological; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors / Q000502:physiology; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D016176:T-Lymphocyte Subsets / Q000378:metabolism / Q000473:pathology
D001549:Benzamides; D016207:Cytokines; D015514:Oncogene Proteins, Fusion; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate